Program Book - Confex

ACR Poster Session A
Wilson 3 and Jerry A. Molitor 3 , 1 University of Minnesota,
Minneapolis, MN, 2 Benaroya Research Institute, Seattle, WA,
3
Univ of MN MMC10 8 , Minneapolis, MN
699. Myocardial Involvement in Systemic Sclerosis As
Assessed by Ultrasonography and Scintigraphic Perfusion
Imaging. Niki Tsifetaki 1 , Charalampos Papagoras 2 , Kersten
Achenbach 3 , Athanasia Georgiou 4 , Spyridon Tsiouris 5 ,
Andreas Fotopoulos 6 and Alexandros A. Drosos 7 , 1 Registrar in
Rheumatology, Ioannina, Greece, 2 Fellow in Rheumatology,
Ioannina, Greece, 3 Cardiologist, Ioannina, Greece, 4 Fellow in
Nuclear Medicine, Ioannina, Greece, 5 Registrar of Nuclear
Medicine, Greece, 6 Associate Professor of Nuclear Medicine,
Greece, 7 Professor of Medicine/Rheumatology, Ioannina,
Greece
700. Prevalence of Celiac Antibodies in Patients with Systemic
Sclerosis. Lindsy J. Forbess 1 , Jessica K. Gordon 1 , Kamini
Doobay 2 , Brian Bosworth 3 , Morgana L. Davids 1 and Robert
Spiera 1 , 1 Hospital for Special Surgery, New York, NY, 2 Hospital
for Special Surgery, New York, 3 New York Presbyterian
Hospital, Weill Cornell Medical Center, New York, NY
701. Pulmonary Hypertension Assessment and Recognition of
Outcomes in Scleroderma: Racial Differences in Systemic
Sclerosis-Related Pulmonary Hypertension. Christine
Peoples 1 , Robyn T. Domsic 1 , Thomas A. Medsger Jr. 1 , Virginia
D. Steen 2 and PHAROS Investigators 3 , 1 Univ of Pittsburgh
Med Ctr, Pittsburgh, PA, 2 Georgetown Univ Medical Center,
Washington, DC, 3 Washington, DC
702. Effects and Safety of Rituximab in Systemic Sclerosis:
An Analysis From the European Scleroderma Trial
and Research Group. Suzana Jordan 1 , Jorg HW Distler 2 ,
Britta Maurer 1 , Jacob M. van Laar 3 , Yannick Allanore 4 ,
Oliver Distler 1 and EUSTAR Rituximab Group 5 , 1 University
Hospital Zurich, Zurich, Switzerland, 2 Department of
Internal Medicine 3 and Institute for Clinical Immunology,
University of Erlangen-Nuremberg, Erlangen, Germany,
3
Musculoskeletal Research Group, Newcastle, United
Kingdom, 4 Paris Descartes University, Rheumatology A
department, Cochin Hospital, Paris, France, 5 Florence, Italy
703. B Cell Depletion Therapy in Systemic Sclerosis: a Follow-up
Study of 4 Years on Skin and Lung Involvement in Fourteen
Patients. Silvia L. Bosello 1 , Antonella Laria 1 , Manuela Rucco 1 ,
Mario Bocci 1 , Giacomo De Luca 1 , Annunziata Capacci 1 ,
Matteo Falcione 2 , Francesco Maria Danza 2 and Gianfranco
Ferraccioli 1 , 1 Division of Rheumatology, Catholic University
of the Sacred Heart, Rome, Italy, 2 Institute of Radiology,
Catholic University of the Sacred Heart, Rome, Italy
704. ELF Score: A Validated Serum Test Strongly Predictive
of Fibrosis in Systemic Sclerosis. Giuseppina Abignano 1 ,
Giovanna Cuomo 2 , Maya H. Buch 1 , William M. Rosenberg 3 ,
Gabriele Valentini 4 , Paul Emery 5 and Francesco Del Galdo 1 ,
1
University of Leeds, Leeds, United Kingdom, 2 Second
University of Naples, Naples, Italy, 3 Centre for Hepatology
- UCL, London, United Kingdom, 4 Second Univ of Napoli,
Napoli, Italy, 5 Leeds Institute of Molecular Medicine,
University of Leeds and NIHR Leeds Musculoskeletal
Biomedical Research Unit, Leeds, UK, Leeds, United
Kingdom
705. Optical Coherence Tomography: A New Imaging Technique
That Allows Detailed Visualization of Affected Scleroderma
Skin. Giuseppina Abignano 1 , Sibel Aydin 2 , Concepcion
Castillo-Gallego Jr. 3 , Maya H. Buch 1 , Paul Emery 4 and
Francesco Del Galdo 1 , 1 University of Leeds, Leeds, United
Kingdom, 2 Goztepe Training and Research Hospital, Istanbul,
Turkey, 3 Hospital Universitario La Paz, Madrid, Spain,
4
NIHR-Leeds Biomedical Research Unit and Leeds Institute
of Molecular Medicine, University of Leeds, Leeds, United
Kingdom
706. Decreased Plasma Ghrelin Levels in Patients with Systemic
Sclerosis. Yuko OTA, Yasushi Kawaguchi, Kae Takagi, Takahisa
Gono, Masanori Hanaoka and Hisashi Yamanaka, Tokyo
Women’s Medical University, Tokyo, Japan
707. A Pilot Study of Abatacept for the Treatment of Patients
with Diffuse Cutaneous Systemic Sclerosis. Eliza F.
Chakravarty 1 , David Fiorentino 2 , Mihoko Bennett 3 and
Lorinda Chung 4 , 1 Oklahoma Medical Research Foundation,
Oklahoma City, OK, 2 Stanford, Stanford, CA, 3 Stanford
University, Palo Alto, CA, 4 Stanford Univ Medical Center, Palo
Alto, CA
708. Clinical Correlates of CENP-A and CENP-B Antibodies
in a Large Cohort of Systemic Sclerosis Patients. Marie
Hudson 1 , Michael Mahler 2 , Janet Pope 3 , Daniel You 4 ,
Solene Tatibouet 1 , Russell Steele 1 , Murray Baron 5 and
Marvin J. Fritzler 4 , 1 McGill University, Montreal, QC, 2 INOVA
Diagnostics, Inc., San Diego, CA, 3 Univ of Western Ontario,
London, ON, 4 University of Calgary, Calgary, AB, 5 Jewish
General Hospital, Montreal, QC
709. Influenza H1N1 Vaccination in Mixed Connective Tissue
Disease: Effectiveness and Safety Independent of Disease
or Therapy. Renata Miossi 1 , Ricardo Fuller 1 , Julio C. B.
Moraes 1 , Ana Cristina Medeiros 1 , Carla G.S. Saad 1 , Nadia
E. Aikawa 1 , Joao Miraglia 2 , Maria A. Ishida 3 , M.Teresa C.
Caleiro 1 and Eloisa Bonfa 1 , 1 University of Sao Paulo, Sao
Paulo, Brazil, 2 Fundação Butantan, São Paulo, Brazil, 3 Adolfo
Lutz Institute, Sao Paulo, Brazil
710. How Do Physicians Make a Global Assessment of
Raynaud’s Phenomenon in a Clinical Trial Richard W.
Martin 1 , Andrew J. Head 2 , James D. Birmingham 1 and Aaron
T. Eggebeen 1 , 1 Michigan State University College of Human
Medicine, Grand Rapids, MI, 2 College of Human Medicine,
Michigan State University, Grand Rapids, MI
711. Tendon and Joint Involvement in Diffuse Systemic Sclerosis:
An Ultrasound and Magnetic Resonance Imaging Study.
Maria S. Stoenoiu 1 , Frederic E. Lecouvet 1 and Frédéric. A.
Houssiau 2 , 1 Cliniques Universitaires Saint-Luc, Brussels,
Belgium, 2 Université catholique de Louvain, Brussels,
Belgium
712. Iloprost Enhances Th17 and Th22 While Decreasing
2011 Program Book 193